JP2023521763A5 - - Google Patents

Info

Publication number
JP2023521763A5
JP2023521763A5 JP2022561415A JP2022561415A JP2023521763A5 JP 2023521763 A5 JP2023521763 A5 JP 2023521763A5 JP 2022561415 A JP2022561415 A JP 2022561415A JP 2022561415 A JP2022561415 A JP 2022561415A JP 2023521763 A5 JP2023521763 A5 JP 2023521763A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide sequence
variable region
chain variable
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022561415A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521763A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/052890 external-priority patent/WO2021205359A1/en
Publication of JP2023521763A publication Critical patent/JP2023521763A/ja
Publication of JP2023521763A5 publication Critical patent/JP2023521763A5/ja
Pending legal-status Critical Current

Links

JP2022561415A 2020-04-08 2021-04-07 抗ｐｈｆ－タウ抗体及びその使用 Pending JP2023521763A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063007118P 2020-04-08 2020-04-08
US63/007,118 2020-04-08
US202063026387P 2020-05-18 2020-05-18
US63/026,387 2020-05-18
PCT/IB2021/052890 WO2021205359A1 (en) 2020-04-08 2021-04-07 Anti-phf-tau antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2023521763A JP2023521763A (ja) 2023-05-25
JP2023521763A5 true JP2023521763A5 (https=) 2024-04-09

Family

ID=78023121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561415A Pending JP2023521763A (ja) 2020-04-08 2021-04-07 抗ｐｈｆ－タウ抗体及びその使用

Country Status (20)

Country Link
US (1) US20230151083A1 (https=)
EP (1) EP4132569A4 (https=)
JP (1) JP2023521763A (https=)
KR (1) KR20220166308A (https=)
CN (1) CN115697393A (https=)
AU (1) AU2021251486A1 (https=)
BR (1) BR112022020410A2 (https=)
CA (1) CA3179914A1 (https=)
CL (1) CL2022002766A1 (https=)
CO (1) CO2022015737A2 (https=)
CR (1) CR20220505A (https=)
DO (1) DOP2022000218A (https=)
EC (1) ECSP22078815A (https=)
IL (1) IL297231A (https=)
JO (1) JOP20220255A1 (https=)
MX (1) MX2022012628A (https=)
PE (1) PE20230385A1 (https=)
PH (1) PH12022553035A1 (https=)
TW (1) TW202204402A (https=)
WO (1) WO2021205359A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3093200A1 (en) 2018-03-05 2019-09-12 Janssen Pharmaceutica Nv Anti-phf-tau antibodies and uses thereof
US20250034559A1 (en) 2021-11-17 2025-01-30 Voyager Therapeutics, Inc. Compositions and methods for the treatment of tau-related disorders
AU2023232448A1 (en) * 2022-03-11 2024-10-24 Janssen Pharmaceutica Nv Multispecific antibodies and uses thereof
CA3254442A1 (en) * 2022-03-11 2023-09-14 Janssen Pharmaceutica Nv MULTISPECIFIC ANTIBODIES AND THEIR USES
KR20250069606A (ko) 2022-09-15 2025-05-19 보이저 테라퓨틱스, 인크. 타우 결합 화합물
WO2025122634A1 (en) 2023-12-05 2025-06-12 Voyager Therapeutics, Inc. Compositions and methods for the treatment of tau-related disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX350311B (es) * 2011-12-20 2017-09-01 Janssen Biotech Inc Anticuerpos anti-phf-tau y sus usos.
WO2016112078A2 (en) * 2015-01-08 2016-07-14 Janssen Biotech, Inc. Anti-phf-tau antibodies and their uses
US10344081B2 (en) * 2015-07-06 2019-07-09 Ucb Biopharma Sprl Tau-binding antibodies
CN106939047B (zh) * 2016-01-04 2021-08-31 江苏怀瑜药业有限公司 一种pd-l1抗体及其制备方法
TWI771389B (zh) * 2017-03-16 2022-07-21 美商健生生物科技公司 抗phf-tau抗體及其用途
US10591492B2 (en) * 2018-03-05 2020-03-17 Janssen Pharmaceutica Nv Assays to detect neurodegeneration
CA3179922A1 (en) * 2020-04-08 2021-10-14 Janssen Biotech, Inc. Anti-cd98 antibodies and uses thereof
CN121754667A (zh) * 2020-04-08 2026-03-31 阿里亚达治疗公司 用于血脑屏障递送的组合物和方法

Similar Documents

Publication Publication Date Title
JP2023521763A5 (https=)
IL310464A (en) Anti-phf-tau antibodies and uses thereof
Gámez-Valero et al. Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies
ES2274869T3 (es) Diagnostico de tauopatias determinando la relacion tau/fosfotau.
JP6071886B2 (ja) 脳損傷のバイオマーカー
CN103782171B (zh) 用于检测流体样品中淀粉状蛋白β寡聚体的方法及其用途
IL225568A (en) Phospho-specific antibodies for tau detection
JP2012530055A5 (https=)
WO2016040903A1 (en) Detection of misfolded amyloid beta protein
JP2018535921A5 (https=)
US20170038397A1 (en) Assay reagents for a neurogranin diagnostic kit
JP2018534236A5 (https=)
US20090258426A1 (en) Preferred segments of neural thread protein and method of using the same
US20200278356A1 (en) Compositions and methods for diagnosing and treating peroxisomal diseases
JP7718270B2 (ja) 血液試料を検体とするタウタンパク質検出方法
JPWO2013175678A1 (ja) ヒト心筋由来トロポニンｉに特異的にかつ速やかに結合できる変異体タンパク質
JP5528643B2 (ja) ヒト心筋由来トロポニンｉに特異的にかつ速やかに結合できる組み換えタンパク質
US20190161756A1 (en) Anti-Immunoglobulin G Aptamers and Uses Thereof
CN118184778A (zh) 一种AD7c-NTP单克隆抗体及其应用
US20130158237A1 (en) Recombinant protein capable of binding specifically and quickly to troponin i derived from human myocardium
US20130143245A1 (en) Recombinant protein capable of binding specifically and quickly to troponin i derived from human myocardium
US20140057267A1 (en) Composition and kit for the diagnosis of mild cognitive impairment, which measure an expression level of lipocalin-2, and method for providing information for the diagnosis of mild cognitive impairment
US20130178606A1 (en) Recombinant protein capable of binding specifically and quickly to troponin i derived from human myocardium
CN115710313A (zh) 用于检测γ干扰素的抗体组合及其应用
JP2008505053A (ja) 単離された多発性硬化症関連細胞傷害性因子、および当該細胞傷害性因子の検出方法